Todd D. Prickett

National Institutes of Health — United States

Medicine · Health Sciences

40h-index9.5kcitations198works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(97), CAR-T cell therapy research(96), Immunotherapy and Immune Responses(76), Cancer Genomics and Diagnostics(46), Immune Cell Function and Interaction(20)

Publications196 total

Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers
Cancer Immunology Immunotherapy·2025Open Access
Supplementary Figure S4 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
Supplementary Figure S1 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
Supplementary Table S2 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
Supplementary Figure S7 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
Data from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
Supplementary Figure S2 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
Supplementary Table S3 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
Supplementary Figure S3 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
Supplementary Table S7 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
Supplementary Figure S5 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
Supplementary Table S6 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
Supplementary Table S4 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
Supplementary Table S1 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
Supplementary Table S5 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
Supplementary Figure S6 from Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
2025Open Access
375  <i>KLF2</i> -overexpression imparts stemness onto dysfunctional neoantigen-reactive human tumor-infiltrating lymphocytes
Regular and Young Investigator Award Abstracts·2025Open Access
A simple circuit to sustain intact tumor microenvironments for complex drug interrogations
2025Open Access
Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
Cancer Discovery·2025· 1 citedOpen Access
Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous Melanoma
Journal of Clinical Oncology·2025· 1 cited
page 1 of 10Next →

Frequent Co-authors

Steven A. Rosenberg(40), Jared J. Gartner(34), Paul F. Robbins(29), Maria R. Parkhurst(20), Anna Pasetto(13), Stephanie L. Goff(12), Yong‐Chen Lu(11), Satyajit Ray(11), Yardena Samuels(11), Frank J. Lowery(11), Zhili Zheng(9), Eric Tran(8), Jessica S. Crystal(8), John R. Wunderlich(8), Nikolaos Zacharakis(8), Xiaomu Wei(8), Sri Krishna(8), Rami Yossef(8), Yong F. Li(8), David L. Brautigan(8)